计算溶液所需的质量、体积或浓度。
CDK9-IN-7 (compound 21e) is a selective, highly potent, and orally active CDK9/cyclin T inhibitor ( IC 50 =11 nM), which exhibits more potent over other CDKs (CDK4/cyclinD=148 nM; CDK6/cyclinD=145 nM). CDK9-IN-7 shows antitumor activity without obvious toxicity. CDK9-IN-7 induces NSCLC cell apoptosis , arrests the cell cycle in the G2 phase, and suppresses the stemness properties of NSCLC
In Vitro
CDK9-IN-7 displays exceptional potency against NSCLC cell lines, especial A549 and H1299 with IC 50 values less than 0.5 µM. In the drug-resistant NSCLC cell line H1975, CDK9-IN-7 also exhibits good inhibition potency with an IC 50 value of 0.837 µM. MCE has not independently confirmed the accuracy of these methods. They are for reference only.
IC50& Target:CDK9/cyclinT1 11 nM (IC 50 ) CDK4/cyclin D 148 nM (IC 50 ) CDK6/cyclinD 145 nM (IC 50 )
通过匹配包装上的批号来查找并下载产品的 COA,每批产品都进行了严格的验证,您可放心使用!
| 批号(Lot Number) | 证书类型 | 货号 |
|---|---|---|
| 分析证书 | C656458 |